Release Date: 21/07/22 11:46 Summary: Suspension from Official Quotation Price Sensitive: Yes Download Document 86.14KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%